MAPK7 and prostate cancer: In an in vitro study on androgen-independent PC3 cells, McCracken et al. [131] described ERK5 overexpresion related to proliferative, migrative, and invasive capabilities, establishing the potential importance of ERK5 in aggressive prostate cancer.